Información del producto
JMJD2 is an enzyme that catalyzes the methylation of histone H3 at lysine 27. JMJD2 inhibitors are compounds that inhibit JMJD2 activity, which may be used to treat cancer. This class of drugs inhibits the activity of JMJD2 by binding to the active site and blocking the substrate from entering. The most potent compound in this class, 5-carboxy-8HQ, has been shown to have antibacterial efficacy in a squamous cell carcinoma model system and up-regulated expression in wild-type cells. Additionally, this compound has been shown to significantly inhibit tumor growth in a mouse model of atherosclerotic lesion.
Propiedades químicas
Consulta técnica sobre: 3D-FAA85278 JMJD2 Inhibitor, 5-carboxy-8HQ
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
